Neuromeka Sets First Issuance Price at 38,350 KRW for 122.6 Billion KRW Rights Offering, CEO's Stake May Drop to 14.26% Raising Dilution Concerns
Neuromeka plans to issue 3,196,465 common shares via a rights offering at a first issuance price of 38,350 KRW per share, raising approximately 122.6 billion KRW. The issue price represents a 21% discount to the current market price of 48,600 KRW.
The new shares account for 25.76% of outstanding shares, causing significant dilution. CEO Park Jong-hoon intends to subscribe to only about 15% of his allocation and may sell some existing shares, potentially reducing the controlling stake from 18.39% to as low as 14.26%. Additional dilution may occur from conversion of remaining convertible bonds and stock option exercises.
Proceeds will be used for debt repayment of 10 billion KRW, facility investment of 76 billion KRW for a new factory and production lines for collaborative and humanoid robots, and 36.58 billion KRW for working capital. After the capital increase, the debt ratio is expected to improve from 101.14% to 19.30%, and the current ratio from 90.53% to 605.33%.
A concurrent bonus issue of 0.5 shares per share is also planned, which will adjust conversion prices and stock option quantities. No share buyback or dividend actions are noted.
[AI Summary]Neuromeka's issuance of 25.76% new shares unavoidably dilutes existing holders, but the funds will largely finance a new factory to drive long-term growth and significantly improve financial health. The decline in CEO stake raises governance concerns, yet the capital raise is strategically aligned with capacity expansion for future revenue growth.
KOSDAQ Filing Information
[Confirmation of Issuance Terms] Securities Registration Statement (Equity Securities)